Bemethyl and cytochrome P450: rat liver and human lymphocytes
Animal research · 2002
- What was studied
- Rat liver after administration; human lymphocytes in vitro
- Main finding
- Reports mixed-type hepatic enzyme induction in rats and concentration-dependent enzyme-activity changes in cultured human lymphocytes.
Reported findings and study design
Rat Bemitil 50 mg/kg orally, single or five administrations; human lymphocytes studied in vitro over a printed concentration range of “0.(1)–100 microM”.
Population or model Rat liver after administration; human lymphocytes in vitro
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Hepatic CYP450/monooxygenase activity | Induction reported | No numerical enzyme fold changes supplied |
| Lymphocyte EROD/BROD response | Concentration-dependent changes reported | Malformed lower concentration bound retained as unresolved |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- The indexed English title says human liver, but the abstract identifies rat liver and human cells in vitro.
- This raises an interaction-research question, not a validated list of human drug interactions.
Source details
Indexed citation and abstract checked; full methods and risk of bias remain unreviewed.
Sources checked
Citation
E. A. Sorokina, S. V. Sibiriak, S. A. Sergeeva. Bemethyl and cytochrome P450: rat liver and human lymphocytes Eksp Klin Farmakol. 65(3):31–34. PMID 12227093